Psych News Alert | schizophrenia (3)

New Schizophrenia Drug Shows Marked Effect on Cognitive Deficits

12/11/24 12:00 AM

FDA Panel Votes 14-1 Against Clozapine REMS

11/20/24 12:00 AM

For Coordinated Specialty Care, Fidelity to Program Components Matters

11/19/24 12:00 AM

Hallucinogen-Related ED Visits Associated With Schizophrenia Risk

11/14/24 12:00 AM

Many Patients With Schizophrenia Benefit From Guided Antipsychotic Tapering Program

10/22/24 12:00 AM

FDA Approves Cobenfy, Antipsychotic With a New Approach to Schizophrenia

9/27/24 12:00 AM

Continuation, Maintenance ECT Lower Risk of Readmission After Acute ECT

9/20/24 12:00 AM

Hormone Therapy May Reduce Relapse Risk for Menopausal Age Women With Schizophrenia

9/18/24 12:00 AM

Researchers Propose Olanzapine and Perphenazine as First-Line Schizophrenia Treatments

9/6/24 12:00 AM